Publications by authors named "Kayo Horibe"

Claim this Profile
M
Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial.
Kayo Horibe, Katsutaro Morino, Itsuko Miyazawa, Sachiko Tanaka-Mizuno, Keiko Kondo

Diabetes Res Clin Practยท April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis